Integrating amyloid imaging and genetics for early risk stratification of Alzheimer's disease
Alzheimer's & Dementia · 2024
DOI: 10.1002/alz.14244 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2024. Verfasst von Bing He und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering and Informatics, Indiana University Luddy School of Informatics, Computing and Engineering, Indianapolis, Indian…. Hauptthemen laut MEDLINE: Alzheimer Disease, Positron-Emission Tomography, Cognitive Dysfunction. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIA NIH HHS, NIH, National Science Foundation.
Themen: Demenz
Abstract (Originalsprache)
INTRODUCTION Alzheimer's disease (AD) initiates years prior to symptoms, underscoring the importance of early detection. While amyloid accumulation starts early, individuals with substantial amyloid burden may remain cognitively normal, implying that amyloid alone is not sufficient for early risk assessment. METHODS Given the genetic susceptibility of AD, a multi‐factorial pseudotime approach was proposed to integrate amyloid imaging and genotype data for estimating a risk score. Validation involved association with cognitive decline and survival analysis across risk‐stratified groups, focusing on patients with mild cognitive impairment (MCI). RESULTS Our risk score outperformed amyloid composite standardized uptake value ratio in correlation with cognitive scores. MCI subjects with lower pseudotime risk score showed substantial delayed onset of AD and slower cognitive decline. Moreover, pseudotime risk score demonstrated strong capability in risk stratification within traditionally defined subgroups such as early MCI, apolipoprotein E ( APOE ) ε4+ MCI, APOE ε4– MCI, and amyloid+ MCI. DISCUSSION Our risk score holds great potential to improve the precision of early risk assessment. Highlights Accurate early risk assessment is critical for the success of clinical trials. A new risk score was built from integrating amyloid imaging and genetic data. Our risk score demonstrated improved capability in early risk stratification.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Engineering and Informatics, Indiana University Luddy School of Informatics, Computing and Engineering, Indianapolis, Indiana, USA.
- Department of Biomedical Engineering and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
- Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, Indiana, USA.
- Department of Mathematics Statistics, University of Vermont, Burlington, Vermont, USA.
ORCID-Profile: Jingwen Yan
Förderung
- NIA NIH HHS
- NIH
- National Science Foundation
- NLM NIH HHS
- National Institutes of Health
- U.S. National Library of Medicine
- National Institute on Aging
Zitieren
APA
He, B., Wu, R., Sangani, N., Pugalenthi, P. V., Patania, A., Risacher, S. L., Nho, K., Apostolova, L. G., Shen, L., Saykin, A. J., Yan, J., & Alzheimer's Disease Neuroimaging Initiative (2024). Integrating amyloid imaging and genetics for early risk stratification of Alzheimer's disease. Alzheimer's & Dementia. https://doi.org/10.1002/alz.14244
Vancouver
He B, Wu R, Sangani N, Pugalenthi PV, Patania A, Risacher SL, et al. Integrating amyloid imaging and genetics for early risk stratification of Alzheimer's disease. Alzheimer's & Dementia. 2024. doi:10.1002/alz.14244
BibTeX
@article{He2024,
author = {He, Bing and Wu, Ruiming and Sangani, Neel and Pugalenthi, Pradeep Varathan and Patania, Alice and Risacher, Shannon L and Nho, Kwangsik and Apostolova, Liana G and Shen, Li and Saykin, Andrew J and Yan, Jingwen and Alzheimer's Disease Neuroimaging Initiative, Alzheimer's Disease Neuroimaging Initiative},
title = {Integrating amyloid imaging and genetics for early risk stratification of Alzheimer's disease},
journal = {Alzheimer's & Dementia},
year = {2024},
doi = {10.1002/alz.14244}
}
EUVIMED